search
Back to results

Caffeine and Neurologic Recovery Following Surgery and General Anesthesia

Primary Purpose

Pain, Postoperative

Status
Completed
Phase
Early Phase 1
Locations
United States
Study Type
Interventional
Intervention
Caffeine Citrate
Dextrose Water
Sponsored by
University of Michigan
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pain, Postoperative focused on measuring Opioid Use, Opioid Dependence, Opioid-Related Disorders, Opioid Abuse, Opioid-use Disorder, Pain, Pain, Postoperative, Cognitive Impairment, Delirium, Delirium on Emergence, Depression, Anxiety, Anxiety Disorders, Affect

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult (>/= 18 years old) undergoing non-cardiac, non-neurologic, non-major vascular surgery requiring general anesthesia

Exclusion Criteria:

  • Emergency surgery
  • Cognitive impairment precluding capacity for informed consent
  • Uncontrolled cardiac arrhythmias
  • Seizure disorders
  • Preoperative opioid use
  • Diabetes
  • Liver failure
  • Pregnancy
  • Breastfeeding
  • Severe visual or auditory impairment (may hinder cognitive function testing)
  • Patients unable to speak English.

Sites / Locations

  • Michigan Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Experimental

Control

Arm Description

Prepared intravenous piggyback solution of caffeine citrate (200 mg caffeine) will be directly delivered to the operating room prior to the surgery of enrolled participants who are randomized to this group.

Prepared intravenous piggyback solution of 5 percent dextrose water will be directly delivered to the operating room prior to the surgery of enrolled participants who are randomized to this group.

Outcomes

Primary Outcome Measures

Cumulative Opioid Consumption: Postoperative Opioid Consumption, Oral Morphine Equivalents (mg)
Postoperative opioid consumption, oral morphine equivalents (mg)

Secondary Outcome Measures

Acute Pain (Patient-reported) as Assessed by Visual Analogue Scale
Visual Analogue Scale (mm, 0-100, 0 = no pain, 100 = worst pain imaginable)
Acute Pain (Observer-reported) as Assessed by Behavioral Pain Scale
Behavioral Pain Scale, on a scale ranging from 3 to 12 when 3 is no pain and 12 is maximum pain
Time Until Anesthetic Emergence
Time from surgical dressing on to anesthetic emergence (min)
Number of Participants With Depression as Assessed by the Hospitalized Anxiety and Depression Scale (HADS-D)
Number (n) of participants with positive screens (score ≥8) using the Hospitalized Anxiety and Depression Scale (HADS-D) (n, 0-21, 0 = normal, 21 = presence of severe depression symptoms)
Number of Participants With Anxiety as Assessed by the Hospitalized Anxiety and Depression Scale (HADS-A)
Number (n) of participants with positive screens (score ≥8) using the Hospitalized Anxiety and Depression Scale (HADS-A) (n, 0-21, 0 = normal, 21 = presence of severe anxiety symptoms)
Cognitive Function as Assessed by Trail Making Test
Trail Making Test scores (seconds, 10-300,10 = fastest reported completion, 300 = maximum time allowed for completion). The change was calculated from the value at post anesthesia minus value at baseline. Higher values are considered to be worse outcomes.
Positive Affect as Assessed by PANAS (Positive and Negative Affect Schedule)
Positive Affect Score (n, 10-50, 10 = least positive affect, 50 = most positive affect) via PANAS (Positive and Negative Affect Schedule)
Negative Affect as Assessed by PANAS (Positive and Negative Affect Schedule)
Negative Affect Score (n, 10-50, 10 = least negative affect, 50 = most negative affect) via PANAS (Positive and Negative Affect Schedule)
Percentage of Delirious Patients Per Group
Number (n) of participants who has experienced at least one episode of delirium by the postoperative day 3 time point, as determined by daily Confusion Assessment Method (CAM).

Full Information

First Posted
June 8, 2018
Last Updated
September 9, 2021
Sponsor
University of Michigan
search

1. Study Identification

Unique Protocol Identification Number
NCT03577730
Brief Title
Caffeine and Neurologic Recovery Following Surgery and General Anesthesia
Official Title
Caffeine and Neurologic Recovery Following Surgery and General Anesthesia
Study Type
Interventional

2. Study Status

Record Verification Date
September 2021
Overall Recruitment Status
Completed
Study Start Date
July 10, 2018 (Actual)
Primary Completion Date
November 21, 2019 (Actual)
Study Completion Date
January 17, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Michigan

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The ongoing opioid epidemic is a public health crisis, and surgical patients are particularly vulnerable to opioid-dependency and related risks. Emerging data suggest that caffeine may reduce pain after surgery. Thus, the purpose of this study is to test whether caffeine reduces pain and opioid requirements after surgery. The investigators will also test whether caffeine improves mood and brain function (e.g., learning, memory) after surgery.
Detailed Description
Opioid-related deaths have quadrupled in the last 20 years, and nearly half of these deaths currently involve prescription opioids. Surgical patients often experience moderate-to-severe pain is common after major surgery, and surgery is associated with a 14-fold increased risk of opioid dependency compared to non-surgical controls, even after minor surgery. Furthermore, mood disorders (e.g., depression) are independently associated with persistent opioid use postoperatively, and signs of postoperative depression are common after major surgery. Thus, given these risk factors, surgical patients are at particularly high risk for opioid dependency postoperatively. Interventions that (1) reduce opioid burden, and (2) improve mood and neuropsychological function may mitigate the risk of postoperative opioid dependency. Preliminary laboratory and clinical findings demonstrate that caffeine may reduce pain after surgery, which may translate to lower opioid requirements. The study tests the hypothesis that intraoperative caffeine administration will improve opioid consumption, pain, and neuropsychological recovery in patients undergoing surgery. Through validated assessment measures, the research team will study the effects of caffeine in relation to postoperative opioid requirements, pain, and neuropsychological (e.g., cognition, depression, anxiety) trajectory after surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Postoperative
Keywords
Opioid Use, Opioid Dependence, Opioid-Related Disorders, Opioid Abuse, Opioid-use Disorder, Pain, Pain, Postoperative, Cognitive Impairment, Delirium, Delirium on Emergence, Depression, Anxiety, Anxiety Disorders, Affect

7. Study Design

Primary Purpose
Treatment
Study Phase
Early Phase 1
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
This will be a single-center, quadruple-blinded, pilot randomized controlled trial at the University of Michigan Health System.
Allocation
Randomized
Enrollment
71 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Experimental
Arm Type
Experimental
Arm Description
Prepared intravenous piggyback solution of caffeine citrate (200 mg caffeine) will be directly delivered to the operating room prior to the surgery of enrolled participants who are randomized to this group.
Arm Title
Control
Arm Type
Placebo Comparator
Arm Description
Prepared intravenous piggyback solution of 5 percent dextrose water will be directly delivered to the operating room prior to the surgery of enrolled participants who are randomized to this group.
Intervention Type
Drug
Intervention Name(s)
Caffeine Citrate
Intervention Description
Prepared intravenous piggyback solutions of caffeine citrate (200 mg caffeine) will be directly delivered to the operating room prior to the surgery of enrolled participants.
Intervention Type
Drug
Intervention Name(s)
Dextrose Water
Intervention Description
Prepared intravenous piggyback solutions of 5 percent dextrose water will be directly delivered to the operating room prior to the surgery of enrolled participants.
Primary Outcome Measure Information:
Title
Cumulative Opioid Consumption: Postoperative Opioid Consumption, Oral Morphine Equivalents (mg)
Description
Postoperative opioid consumption, oral morphine equivalents (mg)
Time Frame
through postoperative day 3
Secondary Outcome Measure Information:
Title
Acute Pain (Patient-reported) as Assessed by Visual Analogue Scale
Description
Visual Analogue Scale (mm, 0-100, 0 = no pain, 100 = worst pain imaginable)
Time Frame
Data gathered from postoperative day 0-3. Final results were based on all values combined over this time period, per protocol.
Title
Acute Pain (Observer-reported) as Assessed by Behavioral Pain Scale
Description
Behavioral Pain Scale, on a scale ranging from 3 to 12 when 3 is no pain and 12 is maximum pain
Time Frame
Data gathered from postoperative day 0-3. Final results were based on all values combined over this time period, per protocol.
Title
Time Until Anesthetic Emergence
Description
Time from surgical dressing on to anesthetic emergence (min)
Time Frame
Duration of time from surgical dressing completion to anesthetic emergence (min); generally expected to be between 10 and 60 minutes
Title
Number of Participants With Depression as Assessed by the Hospitalized Anxiety and Depression Scale (HADS-D)
Description
Number (n) of participants with positive screens (score ≥8) using the Hospitalized Anxiety and Depression Scale (HADS-D) (n, 0-21, 0 = normal, 21 = presence of severe depression symptoms)
Time Frame
baseline through postoperative day 3
Title
Number of Participants With Anxiety as Assessed by the Hospitalized Anxiety and Depression Scale (HADS-A)
Description
Number (n) of participants with positive screens (score ≥8) using the Hospitalized Anxiety and Depression Scale (HADS-A) (n, 0-21, 0 = normal, 21 = presence of severe anxiety symptoms)
Time Frame
baseline through postoperative day 3
Title
Cognitive Function as Assessed by Trail Making Test
Description
Trail Making Test scores (seconds, 10-300,10 = fastest reported completion, 300 = maximum time allowed for completion). The change was calculated from the value at post anesthesia minus value at baseline. Higher values are considered to be worse outcomes.
Time Frame
morning of surgery baseline compared to postanesthesia care unit. Postanesthesia care unit measurement approximately 60 minutes after end of surgery
Title
Positive Affect as Assessed by PANAS (Positive and Negative Affect Schedule)
Description
Positive Affect Score (n, 10-50, 10 = least positive affect, 50 = most positive affect) via PANAS (Positive and Negative Affect Schedule)
Time Frame
postoperative day 3
Title
Negative Affect as Assessed by PANAS (Positive and Negative Affect Schedule)
Description
Negative Affect Score (n, 10-50, 10 = least negative affect, 50 = most negative affect) via PANAS (Positive and Negative Affect Schedule)
Time Frame
postoperative day 3
Title
Percentage of Delirious Patients Per Group
Description
Number (n) of participants who has experienced at least one episode of delirium by the postoperative day 3 time point, as determined by daily Confusion Assessment Method (CAM).
Time Frame
By afternoon of postoperative day (POD) 3
Other Pre-specified Outcome Measures:
Title
Caffeine Intake: Number of Caffeinated Beverages (n) Consumed
Description
Number of caffeinated beverages (n) consumed
Time Frame
postoperative day 0-7
Title
Subacute Opioid Consumption: Postoperative Subacute Opioid Consumption, Oral Morphine Equivalents (mg)
Description
Postoperative subacute opioid consumption, oral morphine equivalents (mg)
Time Frame
postoperative days 4-7
Title
Sleep Disturbances: Incidence (%) of New, Self-reported Sleep Disturbances
Description
Incidence (%) of new, self-reported sleep disturbances
Time Frame
postoperative days 0-3
Title
EEG Spectral Power: Spectral Power (dB) Measured on EEG
Description
Spectral power (dB) measured on EEG
Time Frame
time point 1: anesthetic emergence, approximate measurement 5-10 minutes after surgery end. Time point 2: postanesthesia care unit arrival, approximate measurement 20 minutes after end of surgery
Title
EEG Connectivity: Connectivity (Weighted Phase Lag Index, wPLI) Measured on EEG
Description
Connectivity (weighted phase lag index, wPLI) measured on EEG
Time Frame
time point 1: anesthetic emergence, approximate measurement 5-10 minutes after surgery end. Time point 2: postanesthesia care unit arrival, approximate measurement 20 minutes after end of surgery
Title
Veterans Rand 12 Survey
Description
Comprehensive survey that reports on general health perceptions, physical functioning, role limitations due to physical and emotional problems, bodily pain, energy /fatigue levels, social functioning and mental health. Specifically, a physical and mental health score are reported, with both score scales ranging from 0 (worst possible outcome) to 100 (best possible outcome).
Time Frame
30 days after surgery
Title
Persistent Opioid Use
Description
Incidence of continued opioid use (%) on postoperative day (POD) 30
Time Frame
Postoperative day (POD) 30
Title
Quality of Recovery Survey
Description
Self-report outcome measure evaluating recovery after surgery and anesthesia. Scoring ranges from 3-18, 3=poor 18=excellent
Time Frame
Postoperative day (POD) 1
Title
Richards Campbell Sleep Questionnaire (RCSQ)
Description
Self-report instrument for measuring sleep quality. Visual Analogue Scale (mm, 0-100, 0 =Deep sleep , 100 =Light sleep)
Time Frame
Preoperative (once before surgery on day of surgery)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult (>/= 18 years old) undergoing non-cardiac, non-neurologic, non-major vascular surgery requiring general anesthesia Exclusion Criteria: Emergency surgery Cognitive impairment precluding capacity for informed consent Uncontrolled cardiac arrhythmias Seizure disorders Preoperative opioid use Diabetes Liver failure Pregnancy Breastfeeding Severe visual or auditory impairment (may hinder cognitive function testing) Patients unable to speak English.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Phillip Vlisides, MD
Organizational Affiliation
Assistant Professor of Anesthesiology
Official's Role
Principal Investigator
Facility Information:
Facility Name
Michigan Medicine
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48109
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
26313057
Citation
Weiser TG, Haynes AB, Molina G, Lipsitz SR, Esquivel MM, Uribe-Leitz T, Fu R, Azad T, Chao TE, Berry WR, Gawande AA. Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes. Lancet. 2015 Apr 27;385 Suppl 2:S11. doi: 10.1016/S0140-6736(15)60806-6. Epub 2015 Apr 26.
Results Reference
background
PubMed Identifier
15007400
Citation
Kundermann B, Krieg JC, Schreiber W, Lautenbacher S. The effect of sleep deprivation on pain. Pain Res Manag. 2004 Spring;9(1):25-32. doi: 10.1155/2004/949187.
Results Reference
background
PubMed Identifier
16551935
Citation
Vaurio LE, Sands LP, Wang Y, Mullen EA, Leung JM. Postoperative delirium: the importance of pain and pain management. Anesth Analg. 2006 Apr;102(4):1267-73. doi: 10.1213/01.ane.0000199156.59226.af.
Results Reference
background
PubMed Identifier
9539601
Citation
Lynch EP, Lazor MA, Gellis JE, Orav J, Goldman L, Marcantonio ER. The impact of postoperative pain on the development of postoperative delirium. Anesth Analg. 1998 Apr;86(4):781-5. doi: 10.1097/00000539-199804000-00019.
Results Reference
background
PubMed Identifier
17014605
Citation
Karp JF, Reynolds CF 3rd, Butters MA, Dew MA, Mazumdar S, Begley AE, Lenze E, Weiner DK. The relationship between pain and mental flexibility in older adult pain clinic patients. Pain Med. 2006 Sep-Oct;7(5):444-52. doi: 10.1111/j.1526-4637.2006.00212.x.
Results Reference
background
PubMed Identifier
26909151
Citation
Dolan R, Huh J, Tiwari N, Sproat T, Camilleri-Brennan J. A prospective analysis of sleep deprivation and disturbance in surgical patients. Ann Med Surg (Lond). 2016 Jan 6;6:1-5. doi: 10.1016/j.amsu.2015.12.046. eCollection 2016 Mar.
Results Reference
background
PubMed Identifier
24237004
Citation
Gan TJ, Habib AS, Miller TE, White W, Apfelbaum JL. Incidence, patient satisfaction, and perceptions of post-surgical pain: results from a US national survey. Curr Med Res Opin. 2014 Jan;30(1):149-60. doi: 10.1185/03007995.2013.860019. Epub 2013 Nov 15.
Results Reference
background
PubMed Identifier
28576285
Citation
Avidan MS, Maybrier HR, Abdallah AB, Jacobsohn E, Vlisides PE, Pryor KO, Veselis RA, Grocott HP, Emmert DA, Rogers EM, Downey RJ, Yulico H, Noh GJ, Lee YH, Waszynski CM, Arya VK, Pagel PS, Hudetz JA, Muench MR, Fritz BA, Waberski W, Inouye SK, Mashour GA; PODCAST Research Group. Intraoperative ketamine for prevention of postoperative delirium or pain after major surgery in older adults: an international, multicentre, double-blind, randomised clinical trial. Lancet. 2017 Jul 15;390(10091):267-275. doi: 10.1016/S0140-6736(17)31467-8. Epub 2017 May 30. Erratum In: Lancet. 2017 Jul 15;390(10091):230.
Results Reference
background
PubMed Identifier
18580517
Citation
Pandharipande P, Cotton BA, Shintani A, Thompson J, Pun BT, Morris JA Jr, Dittus R, Ely EW. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma. 2008 Jul;65(1):34-41. doi: 10.1097/TA.0b013e31814b2c4d.
Results Reference
background
PubMed Identifier
19106695
Citation
Robinson TN, Raeburn CD, Tran ZV, Angles EM, Brenner LA, Moss M. Postoperative delirium in the elderly: risk factors and outcomes. Ann Surg. 2009 Jan;249(1):173-8. doi: 10.1097/SLA.0b013e31818e4776.
Results Reference
background
PubMed Identifier
28403427
Citation
Brummett CM, Waljee JF, Goesling J, Moser S, Lin P, Englesbe MJ, Bohnert ASB, Kheterpal S, Nallamothu BK. New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults. JAMA Surg. 2017 Jun 21;152(6):e170504. doi: 10.1001/jamasurg.2017.0504. Epub 2017 Jun 21. Erratum In: JAMA Surg. 2019 Mar 1;154(3):272.
Results Reference
background
PubMed Identifier
22762316
Citation
Saczynski JS, Marcantonio ER, Quach L, Fong TG, Gross A, Inouye SK, Jones RN. Cognitive trajectories after postoperative delirium. N Engl J Med. 2012 Jul 5;367(1):30-9. doi: 10.1056/NEJMoa1112923.
Results Reference
background
PubMed Identifier
18577850
Citation
Bickel H, Gradinger R, Kochs E, Forstl H. High risk of cognitive and functional decline after postoperative delirium. A three-year prospective study. Dement Geriatr Cogn Disord. 2008;26(1):26-31. doi: 10.1159/000140804. Epub 2008 Jun 24.
Results Reference
background
PubMed Identifier
19934879
Citation
Nelson AM, Battersby AS, Baghdoyan HA, Lydic R. Opioid-induced decreases in rat brain adenosine levels are reversed by inhibiting adenosine deaminase. Anesthesiology. 2009 Dec;111(6):1327-33. doi: 10.1097/ALN.0b013e3181bdf894.
Results Reference
background
PubMed Identifier
21857500
Citation
Gauthier EA, Guzick SE, Brummett CM, Baghdoyan HA, Lydic R. Buprenorphine disrupts sleep and decreases adenosine concentrations in sleep-regulating brain regions of Sprague Dawley rat. Anesthesiology. 2011 Oct;115(4):743-53. doi: 10.1097/ALN.0b013e31822e9f85.
Results Reference
background
PubMed Identifier
16192770
Citation
Osman NI, Baghdoyan HA, Lydic R. Morphine inhibits acetylcholine release in rat prefrontal cortex when delivered systemically or by microdialysis to basal forebrain. Anesthesiology. 2005 Oct;103(4):779-87. doi: 10.1097/00000542-200510000-00016.
Results Reference
background
PubMed Identifier
19050611
Citation
Pisani MA, Murphy TE, Araujo KL, Slattum P, Van Ness PH, Inouye SK. Benzodiazepine and opioid use and the duration of intensive care unit delirium in an older population. Crit Care Med. 2009 Jan;37(1):177-83. doi: 10.1097/CCM.0b013e318192fcf9.
Results Reference
background
PubMed Identifier
11313076
Citation
Litaker D, Locala J, Franco K, Bronson DL, Tannous Z. Preoperative risk factors for postoperative delirium. Gen Hosp Psychiatry. 2001 Mar-Apr;23(2):84-9. doi: 10.1016/s0163-8343(01)00117-7.
Results Reference
background
PubMed Identifier
33939649
Citation
Vlisides PE, Li D, McKinney A, Brooks J, Leis AM, Mentz G, Tsodikov A, Zierau M, Ragheb J, Clauw DJ, Avidan MS, Vanini G, Mashour GA. The Effects of Intraoperative Caffeine on Postoperative Opioid Consumption and Related Outcomes After Laparoscopic Surgery: A Randomized Controlled Trial. Anesth Analg. 2021 Jul 1;133(1):233-242. doi: 10.1213/ANE.0000000000005532.
Results Reference
background

Learn more about this trial

Caffeine and Neurologic Recovery Following Surgery and General Anesthesia

We'll reach out to this number within 24 hrs